Creating a mutual understanding between companies and organization, with a focus on healthcare on the one hand and the government and politics on the other, to come to adjustments of policy and decision making with input of our network, our knowledge and experience.
If pharmaceutical and biotechnological companies and / or healthcare institutions feel that they are hindered in offering optimum quality by adjustments of existing, or new, legislation and regulations, BPRA will use all means at its disposal to ensure that political stakeholders influence policy makers to the extent that innovation and qualitative healthcare can and will be improved.
Lobbyists are the link between political The Hague and practice. By representing interests, democratic capacity is generated. However, this must be done fairly and openly. BPRA believes in working transparently and with integrity and therefore endorses the code of conduct by BVPA.